Citations (49)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (14)
Kristin G Bevilacqua, Charell Brinkley, Joseph McGowan, Frances Wallach & Rebecca M Schwartz. (2022) “We are Getting Those Old People Things.” Polypharmacy Management and Medication Adherence Among Adult HIV Patients with Multiple Comorbidities: A Qualitative Study. Patient Preference and Adherence 16, pages 2773-2780.
Read now
Read now
Abiy Tadesse Angelo & Daniel Shiferaw Alemayehu. (2021) Adherence and Its Associated Factors Among Adult HIV-Infected Patients on Antiretroviral Therapy in South Western Ethiopia, 2020. Patient Preference and Adherence 15, pages 299-308.
Read now
Read now
Mark S. Dworkin, Palak Panchal, Wayne Wiebel, Robert Garofalo, Antonio Jimenez & Jessica E. Haberer. (2020) Experience with antiretroviral electronic adherence monitoring among young African American men who have sex with men living with HIV: findings to inform a triaged real-time alert intervention. AIDS Care 32:9, pages 1092-1101.
Read now
Read now
Nils von Hentig. (2016) Clinical use of cobicistat as a pharmacoenhancer of human immunodeficiency virus therapy. HIV/AIDS - Research and Palliative Care 8, pages 1-16.
Read now
Read now
Laura Comi & Franco Maggiolo. (2016) Abacavir + dolutegravir + lamivudine for the treatment of HIV. Expert Opinion on Pharmacotherapy 17:15, pages 2097-2106.
Read now
Read now
Ed L. Wilkins, Calvin J. Cohen, Benoit Trottier, Stefan Esser, Don E. Smith, Bernhard Haas, Cynthia Brinson, Will Garner, Susan Chuck, David Thorpe & Shampa De-Oertel. (2016) Patient-reported outcomes in the single-tablet regimen (STaR) trial of rilpivirine/emtricitabine/tenofovir disoproxil fumarate versus efavirenz/emtricitabine/tenofovir disoproxil fumarate in antiretroviral treatment-naive adults infected with HIV-1 through 48 weeks of treatment. AIDS Care 28:3, pages 401-408.
Read now
Read now
José Luis Casado & Sara Bañón. (2015) Dutrebis (lamivudine and raltegravir) for use in combination with other antiretroviral products for the treatment of HIV-1 infection. Expert Review of Clinical Pharmacology 8:6, pages 709-718.
Read now
Read now
Susana W Keeshin & Judith Feinberg. (2015) Evaluation of dolutegravir safety for the treatment of HIV-1. Expert Opinion on Drug Safety 14:1, pages 141-147.
Read now
Read now
A. Mills, G. Crofoot, R. Ortiz, B. Rashbaum, W. Towner, D. Ward, C. Brinson, R. Kulkarni, W. Garner, R. Ebrahimi, H. Cao, A. Cheng & J. Szwarcberg. (2014) Switching From Twice-Daily Raltegravir Plus Tenofovir Disoproxil Fumarate/Emtricitabine to Once-Daily Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Disoproxil Fumarate in Virologically Suppressed, HIV-1–Infected Subjects: 48 Weeks Data. HIV Clinical Trials 15:2, pages 51-56.
Read now
Read now
Amy S. Baranoski, Elizabeth Meuser, Helene Hardy, Elizabeth F. Closson, Matthew J. Mimiaga, Steven A. Safren, Pushwaz Virk, Rowena Luk, Paul R. Skolnik & Vikram S. Kumar. (2014) Patient and provider perspectives on cellular phone-based technology to improve HIV treatment adherence. AIDS Care 26:1, pages 26-32.
Read now
Read now
Alessandra Fantauzzi, Ombretta Turriziani & Ivano Mezzaroma. (2013) Potential benefit of dolutegravir once daily: efficacy and safety. HIV/AIDS - Research and Palliative Care 5, pages 29-40.
Read now
Read now
Gabriel Rebick & Sharon L Walmsley. (2012) Issues in resistance, adherence, and comparative efficacy of the single-tablet regimen combination of tenofovir, emtricitabine, and efavirenz in the management of HIV-1 infection. Virus Adaptation and Treatment 4, pages 51-63.
Read now
Read now
Charu Taneja, Timothy Juday, Larry Gertzog, John Edelsberg, Todd Correll, Tony Hebden & Gerry Oster. (2012) Adherence and persistence with non-nucleoside reverse transcriptase inhibitor-based antiretroviral regimens. Expert Opinion on Pharmacotherapy 13:15, pages 2111-2118.
Read now
Read now
Steven Han, Kristy Iglay, Michael J. Davies, Qiaoyi Zhang & Larry Radican. (2012) Glycemic effectiveness and medication adherence with fixed-dose combination or coadministered dual therapy of antihyperglycemic regimens: a meta-analysis. Current Medical Research and Opinion 28:6, pages 969-977.
Read now
Read now
Articles from other publishers (35)
Mark S. Dworkin, Palak Panchal, Wayne Wiebel, Robert Garofalo, Jessica E. Haberer & Antonio Jimenez. (2019) A triaged real-time alert intervention to improve antiretroviral therapy adherence among young African American men who have sex with men living with HIV: focus group findings. BMC Public Health 19:1.
Crossref
Crossref
Harinder Singh Chahal, Kalli Koukounas, Peter Capella, Ryan Presto, Jeffrey S. Murray, Martin Shimer, Karen Riley & Mary Lou Valdez. (2019) An Evaluation of US Food and Drug Administration’s Program to Register HIV Drugs for Use in Resource-Constrained Settings. JAMA Network Open 2:11, pages e1915787.
Crossref
Crossref
Priti P. Pednekar, Tamás Ágh, Maria Malmenäs, Amit D. Raval, Bryan M. Bennett, Bijan J. Borah, David S. Hutchins, Elizabeth Manias, Allison F. Williams, Mickaël Hiligsmann, Adina Turcu-Stiolica, John E. Zeber, Lusine Abrahamyan, Thomas J. Bunz & Andrew M. Peterson. (2019) Methods for Measuring Multiple Medication Adherence: A Systematic Review–Report of the ISPOR Medication Adherence and Persistence Special Interest Group. Value in Health 22:2, pages 139-156.
Crossref
Crossref
Patrick G. Clay, Wei C. Yuet, Christiane H. Moecklinghoff, Inge Duchesne, Krzysztof L. Tronczyński, Sandip Shah & Dong Shao. (2018) A meta-analysis comparing 48-week treatment outcomes of single and multi-tablet antiretroviral regimens for the treatment of people living with HIV. AIDS Research and Therapy 15:1.
Crossref
Crossref
Jenna YagerJohn FaragonLiam McGueyAdam Hoye-SimekZachary HecoxSteven SullivanStefanie NeubertNimish Patel. (2017) Relationship Between Single Tablet Antiretroviral Regimen and Adherence to Antiretroviral and Non-Antiretroviral Medications Among Veterans' Affairs Patients with Human Immunodeficiency Virus. AIDS Patient Care and STDs 31:9, pages 370-376.
Crossref
Crossref
Laurent Cotte, Tristan Ferry, Pascal Pugliese, Marc-Antoine Valantin, Clotilde Allavena, André Cabié, Isabelle Poizot-Martin, David Rey, Claudine Duvivier, Antoine Cheret, Pierre Dellamonica, Pierre Pradat & Jean-Jacques Parienti. (2017) Effectiveness and tolerance of single tablet versus once daily multiple tablet regimens as first-line antiretroviral therapy - Results from a large french multicenter cohort study. PLOS ONE 12:2, pages e0170661.
Crossref
Crossref
S. Scott Sutton, Divya Ahuja & Joseph Magagnoli. (2016) What is the effect of pill burden on adherence to HIV antiretroviral therapy?. JAAPA 29:11, pages 16-17.
Crossref
Crossref
Laura De Luca, Fatima E. Agharbaoui, Rosaria Gitto, Maria Rosa Buemi, Frauke Christ, Zeger Debyser & Stefania Ferro. (2016) Rational Design, Synthesis and Evaluation of Coumarin Derivatives as Protein-protein Interaction Inhibitors. Molecular Informatics 35:8-9, pages 460-473.
Crossref
Crossref
Inés Montes-Escalante, Patricia Monje-Agudo, Elena Calvo-Cidoncha, Carmen V Almeida-González & Ramón Morillo-Verdugo. (2016) Design and validation of a predictive model for 1-year hospital admission in HIV patients on antiretroviral treatment. European Journal of Hospital Pharmacy 23:4, pages 224-227.
Crossref
Crossref
Lisa S. Burch, Colette J. Smith, Andrew N. Phillips, Margaret A. Johnson & Fiona C. Lampe. (2016) Socioeconomic status and response to antiretroviral therapy in high-income countries. AIDS 30:8, pages 1147-1161.
Crossref
Crossref
S. Scott Sutton, Joseph Magagnoli & James W. Hardin. (2016) Impact of Pill Burden on Adherence, Risk of Hospitalization, and Viral Suppression in Patients with HIV Infection and AIDS Receiving Antiretroviral Therapy. Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy 36:4, pages 385-401.
Crossref
Crossref
P.G. Clay, S. Nag, C.M. Graham & S. Narayanan. (2015) Meta-Analysis of Studies Comparing Single and Multi-Tablet Fixed Dose Combination HIV Treatment Regimens. Medicine 94:42, pages e1677.
Crossref
Crossref
François Raffi, Yazdan Yazdanpanah, Francis Fagnani, Caroline Laurendeau, Antoine Lafuma & Julie Gourmelen. (2015) Persistence and adherence to single-tablet regimens in HIV treatment: a cohort study from the French National Healthcare Insurance Database. Journal of Antimicrobial Chemotherapy 70:7, pages 2121-2128.
Crossref
Crossref
Stefania Ferro, Laura De Luca, Fatima Ezzahra Agharbaoui, Frauke Christ, Zeger Debyser & Rosaria Gitto. (2015) Optimization of rhodanine scaffold for the development of protein–protein interaction inhibitors. Bioorganic & Medicinal Chemistry 23:13, pages 3208-3214.
Crossref
Crossref
Jean B NachegaOlalekan A UthmanKarl PeltzerLindsey A RichardsonEdward J MillsKofi AmekudziAlice Ouédraogo. (2015) Association between antiretroviral therapy adherence and employment status: systematic review and meta-analysis. Bulletin of the World Health Organization 93:1, pages 29-41.
Crossref
Crossref
Nienke Langebeek, Elizabeth H Gisolf, Peter Reiss, Sigrid C Vervoort, Thóra B Hafsteinsdóttir, Clemens Richter, Mirjam AG Sprangers & Pythia T Nieuwkerk. (2014) Predictors and correlates of adherence to combination antiretroviral therapy (ART) for chronic HIV infection: a meta-analysis. BMC Medicine 12:1.
Crossref
Crossref
José L. Blanco, Julio S.G. Montaner, Vincent C. Marconi, Maria M. Santoro, Ariel E. Campos-Loza, Robert W. Shafer, Michael D. Miller, Roger Paredes, Richard Harrigan, Mihn L. Nguyen, Carlo F. Perno, Lucero A. Gonzalez-Hernandez & José M. Gatell. (2014) Lower prevalence of drug resistance mutations at first-line virological failure to first-line therapy with atripla vs. tenofovir + emtricitabine/lamivudine + efavirenz administered on a multiple tablet therapy. AIDS 28:17, pages 2531-2539.
Crossref
Crossref
Beatriz Jiménez-Montero, José Beceiro, M. Isabel de José-Gómez, M. Isabel González-Tomé, Dolores Gurbindo-Gutierrez, Jorge Martínez-Pérez, M. José Mellado-Peña, M. Luisa Navarro-Gómez, Miguel A. Roa-Francia, Pablo Rojo-Conejo, Jesús Saavedra-Lozano, Santiago Jiménez de Ory & José T. Ramos-Amador. (2014) Once-daily Antiretroviral Therapy in a Cohort of HIV-Infected Children and Adolescents. Pediatric Infectious Disease Journal 33:10, pages 1052-1054.
Crossref
Crossref
Thomas N Kakuda, Tom Van De Casteele, Romana Petrovic, Mark Neujens, Hiba Salih, Magda Opsomer & Richard MW Hoetelmans. (2013) Bioequivalence of a Darunavir/Cobicistat Fixed-Dose Combination Tablet versus Single Agents and Food Effect in Healthy Volunteers. Antiviral Therapy 19:6, pages 597-606.
Crossref
Crossref
Thomas N. Kakuda, Magda Opsomer, Maarten Timmers, Koen Iterbeke, Tom Van De Casteele, Vera Hillewaert, Romana Petrovic & Richard M. W. Hoetelmans. (2014) Pharmacokinetics of darunavir in fixed-dose combination with cobicistat compared with coadministration of darunavir and ritonavir as single agents in healthy volunteers. The Journal of Clinical Pharmacology 54:8, pages 949-957.
Crossref
Crossref
Alessandra Fantauzzi & Ivano Mezzaroma. (2014) Dolutegravir: clinical efficacy and role in HIV therapy. Therapeutic Advances in Chronic Disease 5:4, pages 164-177.
Crossref
Crossref
Noemi Astuti & Franco Maggiolo. (2014) Single-Tablet Regimens in HIV Therapy. Infectious Diseases and Therapy 3:1, pages 1-17.
Crossref
Crossref
Stefania Ferro, Laura De Luca, Giuseppa Lo Surdo, Francesca Morreale, Frauke Christ, Zeger Debyser, Rosaria Gitto & Alba Chimirri. (2014) A new potential approach to block HIV-1 replication via protein–protein interaction and strand-transfer inhibition. Bioorganic & Medicinal Chemistry 22:7, pages 2269-2279.
Crossref
Crossref
Torsak BunupuradahApirudee PanthongPope KosalaraksaJiratchaya WongsabutThanyawee PuthanakitPagakrong LumbiganonThongsuai ChuanjaroenChanasda SopharakThanitta UdompanitWasana PrasitsuebsaiChitsanu PancharoenJintanat Ananworanich. (2014) Simplifying Antiretroviral Therapy to Lopinavir/Ritonavir Monotherapy Did Not Improve Quality of Life and Therapy Adherence in Pretreated HIV-Infected Children. AIDS Research and Human Retroviruses 30:3, pages 260-265.
Crossref
Crossref
Karen Tashima, Gordon Crofoot, Frank L Tomaka, Thomas N Kakuda, Anne Brochot, Tom Van de Casteele, Magda Opsomer, William Garner, Nicolas Margot, Joseph M Custodio, Marshall W Fordyce & Javier Szwarcberg. (2014) Cobicistat-boosted darunavir in HIV-1-infected adults: week 48 results of a Phase IIIb, open-label single-arm trial. AIDS Research and Therapy 11:1, pages 39.
Crossref
Crossref
Paweł Skwara, Monika Bociąga-Jasik, Anna Kalinowska-Nowak, Iwona Sobczyk-Krupiarz & Aleksander Garlicki. (2014) Adherence to single-tablet versus multiple-tablet regimens in the treatment of HIV infection—A questionnaire-based survey on patients satisfaction. HIV & AIDS Review 13:3, pages 95-99.
Crossref
Crossref
Jemma L. O'Connor, Edward M. Gardner, Sharon B. Mannheimer, Alan R. Lifson, Stefan Esser, Edward E. Telzak & Andrew N. Phillips. (2013) Factors Associated With Adherence Amongst 5295 People Receiving Antiretroviral Therapy as Part of an International Trial. The Journal of Infectious Diseases 208:1, pages 40-49.
Crossref
Crossref
N. Weiler, I. Thrun, M. Eberlin, D. Foltys, M. Heise, M. Hoppe-Lotichius, T. Zimmermann, I. Kraemer & G. Otto. (2013) Tacrolimus Effects and Side Effects After Liver Transplantation: Is There a Difference Between Immediate and Extended Release?. Transplantation Proceedings 45:6, pages 2321-2325.
Crossref
Crossref
Danielle P. Porter & Bill Guyer. 2013. Successful Strategies for the Discovery of Antiviral Drugs. Successful Strategies for the Discovery of Antiviral Drugs
482
508
.
Marie Helleberg, Gitte Kronborg, Carsten S Larsen, Gitte Pedersen, Court Pedersen, Lars Nielsen, Alex L Laursen, Niels Obel & Jan Gerstoft. (2013) Decreasing Rate of Multiple Treatment Modifications among Individuals who Initiated Antiretroviral Therapy in 1997–2009 in the Danish HIV Cohort Study. Antiviral Therapy 18:3, pages 345-354.
Crossref
Crossref
Erik De Clercq. 2013. Antiviral Agents. Antiviral Agents
317
358
.
Sandra A. Springer, Azem Dushaj & Marwan M. Azar. (2012) The Impact of DSM-IV Mental Disorders on Adherence to Combination Antiretroviral Therapy Among Adult Persons Living with HIV/AIDS: A Systematic Review. AIDS and Behavior 16:8, pages 2119-2143.
Crossref
Crossref
Silvia Bertagnolio, Andrea De Luca, Marco Vitoria, Shaffiq Essajee, Martina Penazzato, Steven Y Hong, Craig McClure, Chris Duncombe & Michael R Jordan. (2012) Determinants of HIV Drug Resistance and Public Health Implications in Low- and Middle-Income Countries. Antiviral Therapy 17:6, pages 941-953.
Crossref
Crossref
Paul E. Sax, Juliana L. Meyers, Michael Mugavero & Keith L. Davis. (2012) Adherence to Antiretroviral Treatment and Correlation with Risk of Hospitalization among Commercially Insured HIV Patients in the United States. PLoS ONE 7:2, pages e31591.
Crossref
Crossref
Jennifer A. Robinson, Roxanne Jamshidi & Anne E. Burke. (2012) Contraception for the HIV-Positive Woman: A Review of Interactions between Hormonal Contraception and Antiretroviral Therapy. Infectious Diseases in Obstetrics and Gynecology 2012, pages 1-15.
Crossref
Crossref